Hepion Pharmaceuticals
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $48,447,954.

Profit Margin

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA): Profit margin
2013 0 0
2015 0 -14.34M
2016 0 -16.99M
2017 0 -15.02M
2018 0 -9.44M
2019 0 -7.03M
2020 0 -20.35M
2021 0 -32.72M
2022 0 -42.20M
2023 0 -48.92M

HEPA Income Statement (2013 – 2023)

2023 2022 2021 2020 2019 2018 2017 2015 2014 2013
Revenue
Revenue
0000000000
Cost of revenue
67.13K77.46K86.07K34.51K26.73K021.93K21.52K16.35K0
Gross profit
-67.13K-77.46K-86.07K-34.51K-26.73K0-21.93K-21.52K-16.35K0
Operating exp.
Research and development
35.63M33.26M20.39M11.99M3.18M7.59M14.32M15.01M8.40M0
Selling and marketing
000000-583.70K000
Total operating expenses
48.44M43.61M30.40M20.14M7.77M14.59M21.02M20.80M13.95M0
Operating income
-48.44M-45.48M-30.40M-20.14M-7.77M-14.59M-21.04M-20.80M-13.95M0
Other income (expenses), net
-887.11K-1.45M-2.31M-177.27K379.06K4.94M2.12M3.80M-387.89K0
Income before tax
-49.33M-45.08M-32.72M-20.32M-7.94M-9.98M-18.91M-16.99M-14.34M0
Income tax expense
409.02K-2.88M8.85K30.58K-908.68K-536K-3.89M-3.80M387.89K0
Net income
-48.92M-42.20M-32.72M-20.35M-7.03M-9.44M-15.02M-16.99M-14.34M0
Earnings per share
Basic EPS
-12.32-11.07-9.31-42.06-68.88-1.02K-2.17K-7.03K-7.38K0
Diluted EPS
-12.32-11.07-9.31-42.06-68.88-1.02K-2.17K-7.03K-7.38K0
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source